Scientists at IMBA are passionate about discovery and advancing our understanding of biology. They are recognized leaders in their fields, regularly publishing in the top research journals. Contributions from IMBA research groups are of interest to everyone – including scientists, clinicians, and the public. The Research Highlights below summarize some of the most significant discoveries made by IMBA scientists.
Federal ministers visit IMBA
Austrian ministers Faßmann, Gewessler and Schramböck presented the most important guidelines of the new research financing act, which is intended to ensure long-term, growth-oriented financing of the institutions covered by the act and to guarantee more planning security through three-year contracts.
After the press conference, representatives from politics and the media were given exclusive insights into stem cell and organoid research by IMBA's Scientific Director Jürgen Knoblich.
Currently seven groups at IMBA working on a wide variety of stem cell biology topics. The Knoblich lab works on the development of brain organoids in order to be able to investigate diseases such as epilepsy, autism, schizophrenia or brain tumors in more detail. In 2018, the world's first blood-vessel organoids were developed at IMBA, which now make it possible to investigate common diseases such as diabetes directly on human tissue. At the same time, labs at IMBA are working on heart-organoids, gastro and intestinal organoids, and blastoids. The stem cell initiative at IMBA is funded by the Federal Ministry of Science and the City of Vienna.
